| Dr Kenneth Vernon Slack, MD | |
|
7727 Lake Underhill Rd, Orlando, FL 32822-8224 | |
| (407) 303-6413 | |
| Not Available |
| Full Name | Dr Kenneth Vernon Slack |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 17 Years |
| Location | 7727 Lake Underhill Rd, Orlando, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013169879 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | TRN18079 (Florida) | Secondary |
| 208600000X | Surgery | 24792 (Nebraska) | Secondary |
| 207P00000X | Emergency Medicine | ME119973 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sacred Heart Hospital | Pensacola, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Augustine Emergency Physicians Llc | 0143492892 | 60 |
News Archive
Antibodies developed by researchers at Rensselaer Polytechnic Institute are unusually effective at preventing the formation of toxic protein particles linked to Alzheimer's disease and Parkinson's disease, as well as Type 2 diabetes, according to a new study.
Amorfix Life Sciences Ltd. today announced that it has entered into a licensing agreement granting Biogen Idec exclusive worldwide rights to Amorfix's lead amyotrophic lateral sclerosis (ALS) monoclonal antibodies. The antibodies have shown efficacy in animal models of ALS and Biogen Idec will now, at its expense, complete the development and prepare for clinical trials.
RegeneRx Biopharmaceuticals, Inc. reported that data showing that Thymosin beta 4 (Tβ4) "provides both neuroprotection and neurorestoration after traumatic brain injury (TBI)," was published in the current (May 2012) edition of the Journal of Neurosurgery, 116:1081-1092.
Medtronic today launched Medtronic Eureka, a European web-based portal for medical technology innovation designed to help physicians and medical technology inventors to bring their innovative ideas to life.
Diabetes strongly increases the risk of heart failure in all ethnic groups, but early effects of diabetes on the heart may differ depending on whether the subjects are white, African-American, Hispanic or Chinese.
› Verified 8 days ago
| Entity Name | Emergency Physicians Of Central Florida Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326033341 PECOS PAC ID: 1850296567 Enrollment ID: O20031205000109 |
News Archive
Antibodies developed by researchers at Rensselaer Polytechnic Institute are unusually effective at preventing the formation of toxic protein particles linked to Alzheimer's disease and Parkinson's disease, as well as Type 2 diabetes, according to a new study.
Amorfix Life Sciences Ltd. today announced that it has entered into a licensing agreement granting Biogen Idec exclusive worldwide rights to Amorfix's lead amyotrophic lateral sclerosis (ALS) monoclonal antibodies. The antibodies have shown efficacy in animal models of ALS and Biogen Idec will now, at its expense, complete the development and prepare for clinical trials.
RegeneRx Biopharmaceuticals, Inc. reported that data showing that Thymosin beta 4 (Tβ4) "provides both neuroprotection and neurorestoration after traumatic brain injury (TBI)," was published in the current (May 2012) edition of the Journal of Neurosurgery, 116:1081-1092.
Medtronic today launched Medtronic Eureka, a European web-based portal for medical technology innovation designed to help physicians and medical technology inventors to bring their innovative ideas to life.
Diabetes strongly increases the risk of heart failure in all ethnic groups, but early effects of diabetes on the heart may differ depending on whether the subjects are white, African-American, Hispanic or Chinese.
› Verified 8 days ago
| Entity Name | Florida Emergency Physicians Kang And Associates Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811983752 PECOS PAC ID: 0143113878 Enrollment ID: O20040205000687 |
News Archive
Antibodies developed by researchers at Rensselaer Polytechnic Institute are unusually effective at preventing the formation of toxic protein particles linked to Alzheimer's disease and Parkinson's disease, as well as Type 2 diabetes, according to a new study.
Amorfix Life Sciences Ltd. today announced that it has entered into a licensing agreement granting Biogen Idec exclusive worldwide rights to Amorfix's lead amyotrophic lateral sclerosis (ALS) monoclonal antibodies. The antibodies have shown efficacy in animal models of ALS and Biogen Idec will now, at its expense, complete the development and prepare for clinical trials.
RegeneRx Biopharmaceuticals, Inc. reported that data showing that Thymosin beta 4 (Tβ4) "provides both neuroprotection and neurorestoration after traumatic brain injury (TBI)," was published in the current (May 2012) edition of the Journal of Neurosurgery, 116:1081-1092.
Medtronic today launched Medtronic Eureka, a European web-based portal for medical technology innovation designed to help physicians and medical technology inventors to bring their innovative ideas to life.
Diabetes strongly increases the risk of heart failure in all ethnic groups, but early effects of diabetes on the heart may differ depending on whether the subjects are white, African-American, Hispanic or Chinese.
› Verified 8 days ago
| Entity Name | Augustine Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477124808 PECOS PAC ID: 0143492892 Enrollment ID: O20111003000107 |
News Archive
Antibodies developed by researchers at Rensselaer Polytechnic Institute are unusually effective at preventing the formation of toxic protein particles linked to Alzheimer's disease and Parkinson's disease, as well as Type 2 diabetes, according to a new study.
Amorfix Life Sciences Ltd. today announced that it has entered into a licensing agreement granting Biogen Idec exclusive worldwide rights to Amorfix's lead amyotrophic lateral sclerosis (ALS) monoclonal antibodies. The antibodies have shown efficacy in animal models of ALS and Biogen Idec will now, at its expense, complete the development and prepare for clinical trials.
RegeneRx Biopharmaceuticals, Inc. reported that data showing that Thymosin beta 4 (Tβ4) "provides both neuroprotection and neurorestoration after traumatic brain injury (TBI)," was published in the current (May 2012) edition of the Journal of Neurosurgery, 116:1081-1092.
Medtronic today launched Medtronic Eureka, a European web-based portal for medical technology innovation designed to help physicians and medical technology inventors to bring their innovative ideas to life.
Diabetes strongly increases the risk of heart failure in all ethnic groups, but early effects of diabetes on the heart may differ depending on whether the subjects are white, African-American, Hispanic or Chinese.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kenneth Vernon Slack, MD 7727 Lake Underhill Rd, Orlando, FL 32822-8224 Ph: (407) 303-6413 | Dr Kenneth Vernon Slack, MD 7727 Lake Underhill Rd, Orlando, FL 32822-8224 Ph: (407) 303-6413 |
News Archive
Antibodies developed by researchers at Rensselaer Polytechnic Institute are unusually effective at preventing the formation of toxic protein particles linked to Alzheimer's disease and Parkinson's disease, as well as Type 2 diabetes, according to a new study.
Amorfix Life Sciences Ltd. today announced that it has entered into a licensing agreement granting Biogen Idec exclusive worldwide rights to Amorfix's lead amyotrophic lateral sclerosis (ALS) monoclonal antibodies. The antibodies have shown efficacy in animal models of ALS and Biogen Idec will now, at its expense, complete the development and prepare for clinical trials.
RegeneRx Biopharmaceuticals, Inc. reported that data showing that Thymosin beta 4 (Tβ4) "provides both neuroprotection and neurorestoration after traumatic brain injury (TBI)," was published in the current (May 2012) edition of the Journal of Neurosurgery, 116:1081-1092.
Medtronic today launched Medtronic Eureka, a European web-based portal for medical technology innovation designed to help physicians and medical technology inventors to bring their innovative ideas to life.
Diabetes strongly increases the risk of heart failure in all ethnic groups, but early effects of diabetes on the heart may differ depending on whether the subjects are white, African-American, Hispanic or Chinese.
› Verified 8 days ago
Landon Lichtman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 E Rollins St, Orlando, FL 32803 Phone: 407-303-1940 | |
Dr. Julian Andrew Trivino, D.O., M.S. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 7727 Lake Underhill Rd, Orlando, FL 32822 Phone: 407-303-6413 | |
Ramon H Nunez, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 E Rollins St, Orlando, FL 32803 Phone: 407-303-5600 | |
Dr. Steve Wahel Hilwa, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 86 W Underwood St, Suite 200, Orlando, FL 32806 Phone: 407-237-6329 Fax: 407-649-3083 | |
Dr. Hunter Kane Steward, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 52 W Underwood St # Mp31, Orlando, FL 32806 Phone: 321-841-5111 | |
Marc Santambrosio, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 E Rollins St, Orlando, FL 32803 Phone: 407-303-5600 |